Literature DB >> 9298416

Orbital immunocytoma simulating Hodgkin's disease by mimicking Hodgkin- and Reed-Sternberg-like cells.

W Radner1, P Pfoser, W Sega, W Steinmair.   

Abstract

PURPOSE: The present case report describes primary orbital immunocytoma (IgM-kappa) mimicking Hodgkin's disease of the diffuse, lymphocyte predominance type by expressing Hodgkin simulating cells as well as Reed-Sternberg simulating cells (both: H-RS cells). PATIENTS AND METHODS: The patient (87a; male) was admitted to hospital with increasing left upper eyelid protrusion. Computed tomography revealed an unspecific accumulation of soft tissue within the orbit. A biopsy was taken. Light microscopical sections were stained with PAS, Giemsa and haematoxylin-eosin. Immunohistochemistry was performed following standard procedures.
RESULTS: By means of light microscopy, Hodgkin's disease of the diffuse, lymphocyte predominance type was indicated. This initial diagnosis was mainly based on morphological criteria, e.g. the presence of H-RS-like cells. Since staging work-up produced no evidence of systemic disease, immunohistochemistry was performed. It revealed that the misleading cells were H-RS simulating cells. Finally, the diagnosis made was that of immunocytoma (IgM-kappa); stage I EA.
CONCLUSION: The diagnosis of Hodgkin's disease of the diffuse, lymphocyte predominance type is normally based on morphological criteria. However, in very rare cases immunocytomas simulate this variant of Hodgkin's disease by expressing misleading H-RS simulating cells. Thus, immunohistochemical investigations should generally be included in the criteria for the diagnosis of Hodgkin's disease of the diffuse, lymphocyte predominance type. As far as we are aware, primary immunocytoma mimicking this variant of Hodgkin's disease within the orbit has never been reported.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9298416     DOI: 10.1023/a:1005893320516

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  17 in total

1.  Monoclonal antibodies in the diagnosis of Hodgkin's disease. The search for a rational panel.

Authors:  S M Chittal; P Caverivière; R Schwarting; J Gerdes; T Al Saati; F Rigal-Huguet; H Stein; G Delsol
Journal:  Am J Surg Pathol       Date:  1988-01       Impact factor: 6.394

2.  Large B-cell lymphoma rich in T-cells and simulating Hodgkin's disease.

Authors:  S M Chittal; P Brousset; J J Voigt; G Delsol
Journal:  Histopathology       Date:  1991-09       Impact factor: 5.087

3.  Hodgkin's disease in the orbit.

Authors:  D K Sen; H Mohan; P K Chatterjee
Journal:  Int Surg       Date:  1971-03

4.  The nature of the Hodgkin cell. Report of the First International Symposium on Hodgkin's Lymphoma, Köln, Federal Republic of Germany, October 2-3, 1987.

Authors:  H G Drexler; B F Leber
Journal:  Blut       Date:  1988-03

5.  A Hodgkin cell-specific antigen is expressed on a subset of auto- and alloactivated T (helper) lymphoblasts.

Authors:  R Andreesen; J Osterholz; G W Löhr; K J Bross
Journal:  Blood       Date:  1984-06       Impact factor: 22.113

6.  Evidence of Sternberg-Reed cells being derived from activated lymphocytes.

Authors:  H Stein; J Gerdes; H Lemke; D Y Mason
Journal:  Haematol Blood Transfus       Date:  1985

7.  Hodgkin's disease, lymphocyte predominance type, nodular--further evidence for a B cell derivation. L & H variants of Reed-Sternberg cells express L26, a pan B cell marker.

Authors:  G S Pinkus; J W Said
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

8.  Lymphoplasmacytic/lymphoplasmacytoid immunocytoma with a high content of epithelioid cells. Histologic and immunohistochemical findings.

Authors:  E Patsouris; H Noël; K Lennert
Journal:  Am J Surg Pathol       Date:  1990-07       Impact factor: 6.394

9.  Reed-Sternberg-like cells in low-grade lymphomas are transformed neoplastic cells of B-cell lineage.

Authors:  S S Shin; J Ben-Ezra; J S Burke; K Sheibani; H Rappaport
Journal:  Am J Clin Pathol       Date:  1993-06       Impact factor: 2.493

10.  Orbital lymphoid neoplasms: a clinicopathologic study of 60 patients.

Authors:  D M Knowles; F A Jakobiec
Journal:  Cancer       Date:  1980-08-01       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.